AtMS for Alleviating Posttraumatic Peripheral Neuropathic Pain (PTP-NP)
The goal of this clinical trial is to learn if adaptative transcutaneous magnetic stimulation (AtMS) works to reduce pain caused by post-traumatic peripheral neuropathic pain (PTP-NP) within Veterans and/or active duty military personnel. It will also learn about the safety of AtMS. The main questions it aims to answer are: 1. What are the effects of adaptative tMS (AtMS) in alleviating patients' PTP-NP compared to fixed tMS (FtMS) and Sham-tMS? 2. What are the effects of AtMS in improving functions in patients suffering from PTP-NP compared to FtMS and Sham-tMS? 3. What are the effects of AtMS in improving mood in patients suffering from PTP NP compared FtMS and Sham-tMS? Researchers will compare AtMS, FtMS and Sham-tMS to see if AtMS is the best form of tMS in treating PTP-NP. Participants will undergo the following: 1. Receive a total of 8 AtMS, FtMS, or Sham-tMS treatments over 16 weeks. 2. Visit the clinic a total of 12 times for assessments, check ups, and treatments. 3. Keep a daily diary of their PTP-NP intensity, sleep interference, and pain medications used.
• Veterans (men or women) of any race or ethnicity who are at least 18 years of age
• Chronic peripheral neuropathic pain present for more than 4 months after a traumatic or surgical event per medical history
• Have an average daily Numerical Pain Rating Scale (NPRS) score \> 3
• At least one negative or positive sensory sign or symptom confined to innervation territory of the lesioned nervous structure
• Prior diagnostic tests confirming lesion or disease explaining neuropathic